¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fatty infiltration"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fatty cirrhosis
    Áö¹æ°£°æÈ­(Áõ)
  • fatty degeneration
    Áö¹æº¯¼º
  • fatty food intolerance
    Áö¹æ½Ä¸ø°ßµõ(Áõ)
  • fatty heart
    Áö¹æ½ÉÀå
  • fatty oil
    Áö¹æÀ¯
  • fatty stool
    Áö¹æº¯
  • fatty streak
    Áö¹æÁÙ¹«´Ì, Áö¹æ¼±Á¶
  • free fatty acid
    À¯¸®Áö¹æ»ê
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê
  • saturated fatty acid
    Æ÷È­Áö¹æ»ê
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • fatty cast
    Áö¹æ¿øÁÖ
  • fatty change
    Áö¹æº¯¼º
  • fatty
    Áö¹æ-
  • fatty stool
    Áö¹æº¯
  • fatty streak
    Áö¹æÁÙ¹«´Ì
  • fatty food intolerance
    Áö¹æ½Ä¸ø°ßµõ(Áõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • purulent infiltration
    È­³ó¼º ħÀ±(ûùÒÛàõ öÙëÈ)
  • round cell infiltration
    ¿øÇü¼¼Æ÷ħÀ±
  • round cell infiltration
    ¿øÇü¼¼Æ÷ħÀ±(¡­öÙëÈ)
  • tumor infiltration lymphocyte
    Á¾¾çħÀ±¸²ÇÁ±¸
  • atherosclerosis,fatty sterak
    Áö¹æ¼±Á¶(ò·Û¸¼±Á¶)
  • blown fatty oil
    ÃëÀÔÁö¹æÀ¯(ö£ ò·Û¸êú).
  • essential fatty acid
    Çʼö(ù±âÎ)Áö¹æ»ê(ò·Û¸ß«)
  • essential fatty acids
    ÇʼöÁö¹æ»ê.
  • fatty
    Áö¹æ(ò·Û¸)ÀÇ.
  • fatty acid
    Áö¹æ»ê(¡­ß«)
  • fatty acid
    Áö¹æ»ê(ò·Û¸ß«)
  • fatty acid =FA
    Áö¹æ»ê(ò·Û¸ß«).
  • fatty acids
    Áö¹æ»ê
  • fatty cast
    Áö¹æ¿øÁÖ(ò·Û¸ê­ñº)
  • fatty change
    Áö¹æ º¯¼º(¡­Ü¨à÷)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • free fatty acids
    À¯¸® Áö¹æ»ê(ë´×îò·Û¸ß«)
  • iso fatty acid
    ¾ÆÀ̼ÒÁö¹æ»ê(ò·Û¸ß«)
  • long-chain fatty acid thiokinase
    ±ä»ç½½Áö¹æ»ê(ò·Û¸ß«) Ƽ¿ÀÄ«À̳×À̽º
  • medium-chain fatty acid thiokinase
    Áß(ñé)»ç½½ Áö¹æ»ê(ò·Û¸ß«) Ä¡¿ÀÄ«À̳×À̽º
  • monoenoic fatty acid
    ÀÏ(ìé)¿£ Áö¹æ»ê(ò·Û¸ß«)
  • odd-numbered fatty acid
    Ȧ¼ö Áö¹æ»ê(ò·Û¸ß«)
  • polyenoic fatty acid
    Æú¸®¿¡³ëÀÎ Áö¹æ»ê(ò·Û¸ß«)
  • polyunsaturated fatty acid
    ´ÙºÒÆ÷È­ Áö¹æ»ê(ÒýÝÕøéûúò·Û¸ß«)
  • saturated fatty acid
    Æ÷È­ Áö¹æ»ê(øéûùò·Û¸ß«)
  • unsaturated fatty acid
    ºÒÆ÷È­(ÝÕøéûú) Áö¹æ»ê(ò·Û¸ß«)
  • very long-chain fatty acids
    ¸Å¿ì ±ä »ç½½ Áö¹æ»ê(ò·Û¸ß«)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pulmonary infiltration
    ÆóħÀ±
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PVI patient video interview; peripheral vascular insufficiency; perivascular infiltration; positron volu...
FA   1) Fatty Acid
  2) Fluorescent Antibodies; Çü±¤ Ç×ü
FFA Free Fatty Acid; À¯¸® Áö¹æ»ê
VLCFA Very Long Chain Fatty Acids
AFLP acute fatty liver of pregnancy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EFA Essential Fatty Acid
EFAD Essential Fatty Acid Deficient
EFAD Essential fatty acid deficiency
FABPPM Fatty Acid Binding Protein
FAME Fatty Acid Methyl Ester
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fatty coating of surface
    Ç¥¸éÀÌ Áö¹æÀ¸·Î µ¤Çô ÀÖ´Â
  • fatty film
    Áö¹æÃþ, Áö¹æ ¸·
  • fatty liver
    Áö¹æ °£
    ¼ú, °ú½Ä, ºñ¸¸, ´ç´¢º´, ¾à¹° µîÀÇ ¿øÀο¡ ÀÇÇØ °£ ¼¼Æ÷¿¡ Áö¹æÀÌ °ú´Ù ÃàÀûµÇ¾î Á¦ ±â´ÉÀ» ¸øÇÏ´Â »óÅÂ.
  • fatty metamorphosis
    Áö¹æ º¯È­, Áö¹æ º¯¼º, Áö¹æ º¯
  • fatty streak
    Áö¹æ¼º ¶ì, Áö¹æ ¼±Á¶
    µ¿¸Æ³»¿¡ ÁÖ·Î ÄÝ·¹½ºÅ×·Ñ¿¡ ÀÇÇÏ¿© ±¸¼ºµÈ ÀÛÀº ÆíÆòÇÑ È²È¸»ö ºÎÀ§. ¾Æ¸¶µµ Á×»ó µ¿¸Æ °æÈ­ÁõÀÇ ÃʱâÀÏ °ÍÀÌ´Ù. Á÷°æÀÌ 1mm ÀÌÇÏÀÎ ´Ù¹ß¼º Ȳ»ö Á¡À¸·Î ½ÃÀÛÇÏ¸ç ÆøÀÌ 1-2mmÀÌ°í ±æÀ̰¡ 1cm Á¤µµÀÇ ¼±Á¶°¡ µÈ´Ù. Áö¹æ ¼±Á¶´Â ÁöÁú·Î ±¸¼ºµÈ Æ÷¸» ¼¼Æ÷·Î ±¸¼ºµÇ¾î ÀÖ´Ù. T-¼¼Æ÷, ¼¼Æ÷ÀÇ ÁöÁúÀÌ Á×Á¾¼º ÆÇº¸´Ù Àû°Ô ÀÖ°í, ÇÁ·ÎÅ׿À±Û¸®Ä­, ÄݶóÁ¨ ¹× ź·Â ¼¶À¯µµ ´Ù¾çÇÑ Á¤µµ·Î Á¸ÀçÇÑ´Ù. Áö¿ª, ÀÎÁ¾, ¼ºº° ȤÀº ȯ°æ¿¡ °ü°è¾øÀÌ 1³â ÀÌ»óµÈ ¼Ò¾ÆÀÇ ´ëµ¿¸Æ¿¡ ³ªÅ¸³ª°í °ü»ó µ¿¸Æ Áö¹æ ¼±Á¶´Â »çÃá±â¿¡ ½ÃÀ۵Ǹç, Á×Á¾¼º ÆÇÀÌ ¹ß»ýµÇ´Â ÇØºÎÇÐÀûÀÎ À§Ä¡¿Í ÀÏÄ¡ÇÑ´Ù.
  • free fatty acid
    À¯¸® Áö¹æ»ê
  • no fatty coating
    ºñ Áö¹æ¼º ÇǺ¹
  • polyunsaturate fatty acid
    ´ÙºÒÆ÷È­ Áö¹æ»ê
  • saturated fatty acid
    Æ÷È­ Áö¹æ»ê
  • serum free fatty acid
    Ç÷û À¯¸® Áö¹æ»ê Á¤·®
    Á¤»óÄ¡´Â Á¶±â °øº¹ ½Ã 200-600¥ìEq/l·Î »ý¸®Àû º¯µ¿ÀÌ Å©´Ù.
  • subcutaneous fatty tissue
    ÇÇÇÏ Áö¹æ Á¶Á÷
  • total fatty acids
    ÃÑ Áö¹æ»ê
  • unesterified fatty acid
    ºñ¿¡½ºÅ׸£È­ Áö¹æ»ê
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
branched-chain fatty acid synthetase <enzyme> Analogous to fatty acid synthetase complex but starting with a branched chain keto acid; from bacillis subtilis
Registry number: EC 2.3.1.-
Synonym: bcfa synthetase
(26 Jun 1999)
volatile fatty acid number An index of the volatile acid content of a fat; the number of milliliters of 0.1 n KOH required to neutralise the soluble volatile fatty acids in 5 g of fat that has been saponified, acidified to liberate the fatty acids, and then steam-distilled.
Synonym: volatile fatty acid number.
(05 Mar 2000)
monounsaturated fatty acids A fatty acid chain with at least two empty spaces that could be hydrogenated (have a hydrogen atom added). Saturated (hydrogenated) fatty acids are a greater health risk for the development of atherosclerotic vascular disease.
(27 Sep 1997)
polyenoic fatty acid isomerase <enzyme> Catalyses conversion of arachidonic acid and 5,8,11,14,17-eicosapentaenoic acid to 5,7,9,14-eicosatetraenoic acid and 5,7,9,14,17-eicosapentaenoic acid, respectively
Registry number: EC 5.3.3.-
Synonym: pfi enzyme
(26 Jun 1999)
saturated fatty acid A fatty acid, the carbon chain of which contains no ethylenic or other unsaturated linkages between carbon atoms (e.g., stearic acid and palmitic acid); called saturated because it is incapable of absorbing any more hydrogen.
(05 Mar 2000)
saturated fatty acids In eukaryotic membranes refers to stearic, palmitic and myristic acids, that are linear aliphatic chains with no double bonds. Prokaryotes have numerous branched chain saturated fatty acids.
(18 Nov 1997)
xenobiotic medium chain fatty acid - coenzyme A ligase <enzyme> Partial amino acid sequence of enzyme from bovine liver mitochondria given I first source; has high sequence homology to human and rat sa protein
Registry number: EC 6.2.1.-
Synonym: xl-i ligase, xl-i carboxylic acid - CoA ligase
(26 Jun 1999)
delta-13 fatty acid desaturase <enzyme> Involved in sex pheromone biosynthesis from palmitic acid in the moth thaumetopoea pityocampa, acts in conjunction with an 11-desaturase
Registry number: EC 1.14.99.-
Synonym: delta-13 desaturase
(26 Jun 1999)
delta-22 fatty acid desaturase <enzyme> Involved in ergosterol biosynthesis
Registry number: EC 1.14.99.-
Synonym: ergosta-5,7-dien-3 beta-ol delta-22 desaturase
(26 Jun 1999)
diethenoid fatty acid A fatty acid containing two double bonds, e.g., linoleic acid.
(05 Mar 2000)
omega-3 fatty acid desaturase <enzyme> Catalyses desaturation of the omega-3 carbon (3rd from free end) of c-18 fatty acids; deficiency results in accumulation of linoleic acid (18:2omega6,9) at the expense of linolenic acid (18:3omega3,6,9); amino acid sequence given in first source
Registry number: EC 1.14.99.-
Synonym: fad3 gene product, omega-3 desaturase
(26 Jun 1999)
omega 3 fatty acids A class of fatty acids that have a double bond three carbons from the methyl moiety; reportedly, they play a role in lowering cholesterol and LDL levels.
Synonym: omega-3 fatty acids.
(05 Mar 2000)
essential fatty acid <biochemistry> The three fatty acids required for growth in mammals, arachidonic, linolenic and linoleic acids. Only linoleic acid needs to be supplied in the diet, the other two can be made from it.
(18 Nov 1997)
unesterified free fatty acid Free fatty acids which occur in plasma as a result of lipolysis in adipose tissue or when plasma triacylglycerols are taken into tissues.
(05 Mar 2000)
fatty Containing fat, or having the qualities of fat; greasy; gross; as, a fatty substance.
<medicine> Fatty acid, a tumour consisting of fatty or adipose tissue; lipoma.
Source: Websters Dictionary
(01 Mar 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á